ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Alessandra Gennari
1
,
Fabrice Andre
2
,
Carlos P Barrios
3
,
J. Cort??s
4
,
Evandro de Azambuja
5
,
A. DeMichele
6
,
Rebecca Alexandra Dent
7
,
D. R. Fenlon
8
,
Joseph Gligorov
9
,
Sara A. Hurvitz
10
,
S A Im
11
,
David Krug
12
,
W. S. Kunz
13
,
Sherene Loi
14
,
Frédérique Penault-Llorca
15
,
J. Ricke
16, 17
,
Mark Robson
18
,
Hope S. Rugo
19
,
Cristina Saura
20
,
P G Schmid
21
,
C. F. Singer
22
,
T Spanic
23
,
Sara M. Tolaney
24
,
N. C. TURNER
25
,
Giuseppe Curigliano
26
,
Peter A. Fasching
27
,
Shani Paluch-Shimon
28
,
2
3
Oncology Research Center, Grupo Oncoclínicas, Porto Alegre, Brazil
|
4
International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain
|
12
15
16
20
23
Europa Donna Slovenia, Slovenia, USA
|
25
The Royal Marsden Hospital, NHS Foundation Trust, London, UK.
|
26
27
GBG Forschungs GmbH, Neu-Isenburg, Germany
|
28
29
Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany
|
Publication type: Journal Article
Publication date: 2021-12-01
scimago Q1
wos Q1
SJR: 19.072
CiteScore: 70.4
Impact factor: 65.4
ISSN: 09237534, 15698041
PubMed ID:
34678411
Oncology
Hematology
Abstract
Metastatic breast cancer (MBC) is an incurable disease, but survival improvements have been reported with appropriate therapeutic strategies.1-8 Systemic therapy is the standard-of-care in MBC but may be supplemented with locoregional treatments (LRTs) according to the disease status of the individual patient. Thus, a multidisciplinary team (MDT) is a prerequisite for optimal management. These guidelines are based on breast cancer (BC) biological subtypes even though modern targeted drugs may lead to revisions of these subtypes in the future, as exemplified by the first tumour-agnostic approvals.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
|
|
|
Cancers
62 publications, 6.15%
|
|
|
Breast
37 publications, 3.67%
|
|
|
Frontiers in Oncology
34 publications, 3.37%
|
|
|
Cancer Treatment Reviews
30 publications, 2.98%
|
|
|
ESMO Open
29 publications, 2.88%
|
|
|
Breast Cancer Research and Treatment
28 publications, 2.78%
|
|
|
European Journal of Cancer
21 publications, 2.08%
|
|
|
Journal of Clinical Oncology
19 publications, 1.88%
|
|
|
Annals of Oncology
17 publications, 1.69%
|
|
|
Future Oncology
16 publications, 1.59%
|
|
|
Therapeutic Advances in Medical Oncology
13 publications, 1.29%
|
|
|
Current Oncology
13 publications, 1.29%
|
|
|
npj Breast Cancer
13 publications, 1.29%
|
|
|
Clinical Breast Cancer
13 publications, 1.29%
|
|
|
Critical Reviews in Oncology/Hematology
13 publications, 1.29%
|
|
|
BMC Cancer
12 publications, 1.19%
|
|
|
Journal of Clinical Medicine
11 publications, 1.09%
|
|
|
International Journal of Molecular Sciences
11 publications, 1.09%
|
|
|
Breast Cancer Research
10 publications, 0.99%
|
|
|
Nature Medicine
9 publications, 0.89%
|
|
|
Scientific Reports
8 publications, 0.79%
|
|
|
Oncologist
8 publications, 0.79%
|
|
|
Diagnostics
7 publications, 0.69%
|
|
|
Targeted Oncology
7 publications, 0.69%
|
|
|
Annals of Translational Medicine
7 publications, 0.69%
|
|
|
Cureus
7 publications, 0.69%
|
|
|
Current Opinion in Oncology
6 publications, 0.6%
|
|
|
The Lancet Oncology
6 publications, 0.6%
|
|
|
Breast Cancer
6 publications, 0.6%
|
|
|
10
20
30
40
50
60
70
|
Publishers
|
50
100
150
200
250
300
|
|
|
Elsevier
263 publications, 26.09%
|
|
|
Springer Nature
231 publications, 22.92%
|
|
|
MDPI
136 publications, 13.49%
|
|
|
Frontiers Media S.A.
55 publications, 5.46%
|
|
|
Taylor & Francis
53 publications, 5.26%
|
|
|
Wiley
45 publications, 4.46%
|
|
|
American Society of Clinical Oncology (ASCO)
31 publications, 3.08%
|
|
|
SAGE
27 publications, 2.68%
|
|
|
Oxford University Press
18 publications, 1.79%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
17 publications, 1.69%
|
|
|
AME Publishing Company
14 publications, 1.39%
|
|
|
American Association for Cancer Research (AACR)
9 publications, 0.89%
|
|
|
BMJ
8 publications, 0.79%
|
|
|
American Medical Association (AMA)
8 publications, 0.79%
|
|
|
Georg Thieme Verlag KG
7 publications, 0.69%
|
|
|
Massachusetts Medical Society
6 publications, 0.6%
|
|
|
Public Library of Science (PLoS)
4 publications, 0.4%
|
|
|
Walter de Gruyter
4 publications, 0.4%
|
|
|
Remedium, Ltd.
4 publications, 0.4%
|
|
|
Consilium Medicum
4 publications, 0.4%
|
|
|
OAE Publishing Inc.
4 publications, 0.4%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 0.3%
|
|
|
Spandidos Publications
3 publications, 0.3%
|
|
|
Society of Nuclear Medicine
3 publications, 0.3%
|
|
|
Society for Translational Oncology
3 publications, 0.3%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 0.3%
|
|
|
Alfmed LLC
2 publications, 0.2%
|
|
|
JMIR Publications
2 publications, 0.2%
|
|
|
Publishing House ABV Press
2 publications, 0.2%
|
|
|
50
100
150
200
250
300
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1k
Total citations:
1010
Citations from 2024:
618
(61.31%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Gennari A. et al. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer // Annals of Oncology. 2021. Vol. 32. No. 12. pp. 1475-1495.
GOST all authors (up to 50)
Copy
Gennari A., Andre F., Barrios C. P., Cort??s J., de Azambuja E., DeMichele A., Dent R. A., Fenlon D. R., Gligorov J., Hurvitz S. A., Im S. A., Krug D., Kunz W. S., Loi S., Penault-Llorca F., Ricke J., Robson M., Rugo H. S., Saura C., Schmid P. G., Singer C. F., Spanic T., Tolaney S. M., TURNER N. C., Curigliano G., Fasching P. A., Paluch-Shimon S., Harbeck N. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer // Annals of Oncology. 2021. Vol. 32. No. 12. pp. 1475-1495.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.annonc.2021.09.019
UR - https://doi.org/10.1016/j.annonc.2021.09.019
TI - ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
T2 - Annals of Oncology
AU - Gennari, Alessandra
AU - Andre, Fabrice
AU - Barrios, Carlos P
AU - Cort??s, J.
AU - de Azambuja, Evandro
AU - DeMichele, A.
AU - Dent, Rebecca Alexandra
AU - Fenlon, D. R.
AU - Gligorov, Joseph
AU - Hurvitz, Sara A.
AU - Im, S A
AU - Krug, David
AU - Kunz, W. S.
AU - Loi, Sherene
AU - Penault-Llorca, Frédérique
AU - Ricke, J.
AU - Robson, Mark
AU - Rugo, Hope S.
AU - Saura, Cristina
AU - Schmid, P G
AU - Singer, C. F.
AU - Spanic, T
AU - Tolaney, Sara M.
AU - TURNER, N. C.
AU - Curigliano, Giuseppe
AU - Fasching, Peter A.
AU - Paluch-Shimon, Shani
AU - Harbeck, Nadia
PY - 2021
DA - 2021/12/01
PB - Elsevier
SP - 1475-1495
IS - 12
VL - 32
PMID - 34678411
SN - 0923-7534
SN - 1569-8041
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Gennari,
author = {Alessandra Gennari and Fabrice Andre and Carlos P Barrios and J. Cort??s and Evandro de Azambuja and A. DeMichele and Rebecca Alexandra Dent and D. R. Fenlon and Joseph Gligorov and Sara A. Hurvitz and S A Im and David Krug and W. S. Kunz and Sherene Loi and Frédérique Penault-Llorca and J. Ricke and Mark Robson and Hope S. Rugo and Cristina Saura and P G Schmid and C. F. Singer and T Spanic and Sara M. Tolaney and N. C. TURNER and Giuseppe Curigliano and Peter A. Fasching and Shani Paluch-Shimon and Nadia Harbeck},
title = {ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer},
journal = {Annals of Oncology},
year = {2021},
volume = {32},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/j.annonc.2021.09.019},
number = {12},
pages = {1475--1495},
doi = {10.1016/j.annonc.2021.09.019}
}
Cite this
MLA
Copy
Gennari, Alessandra, et al. “ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.” Annals of Oncology, vol. 32, no. 12, Dec. 2021, pp. 1475-1495. https://doi.org/10.1016/j.annonc.2021.09.019.